425 related articles for article (PubMed ID: 12640630)
21. Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia.
Yahouédéhou SCMA; da Guarda CC; Figueiredo CVB; Santiago RP; Carvalho SP; Fiuza LM; Ndidi US; Oliveira RM; Carvalho MOS; Nascimento VML; Rocha LC; Lyra IM; Adorno EV; Goncalves MS
PLoS One; 2019; 14(7):e0218040. PubMed ID: 31306416
[TBL] [Abstract][Full Text] [Related]
22. Effect of hydroxyurea on immature reticulocyte fraction in sickle cell anemia.
Bagdasaryan R; Glasser L; Quillen K; Chaves F; Xu D
Lab Hematol; 2007; 13(3):93-7. PubMed ID: 17984040
[TBL] [Abstract][Full Text] [Related]
23. Increasing fetal hemoglobin production in sickle cell disease: results of clinical trials.
Dover GJ; Charache S
Prog Clin Biol Res; 1987; 251():455-66. PubMed ID: 2448813
[TBL] [Abstract][Full Text] [Related]
24. Neutrophils remain detrimentally active in hydroxyurea-treated patients with sickle cell disease.
Barbu EA; Dominical VM; Mendelsohn L; Thein SL
PLoS One; 2019; 14(12):e0226583. PubMed ID: 31869367
[TBL] [Abstract][Full Text] [Related]
25. Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy.
Saleh AW; Hillen HF; Duits AJ
Acta Haematol; 1999; 102(1):31-7. PubMed ID: 10473885
[TBL] [Abstract][Full Text] [Related]
26. Enhancing Effect of Hydroxyurea on Hb F in Sickle Cell Disease: Ten-Year Egyptian Experience.
Youssry I; Abdel-Salam A; Ismail R; Bou-Fakhredin R; Mohamed Samy R; Ezz El-Deen F; Taher AT
Hemoglobin; 2017; 41(4-6):267-273. PubMed ID: 29251012
[TBL] [Abstract][Full Text] [Related]
27. Absolute Reticulocyte Count Acts as a Surrogate for Fetal Hemoglobin in Infants and Children with Sickle Cell Anemia.
Meier ER; Byrnes C; Weissman M; Lee YT; Miller JL
PLoS One; 2015; 10(9):e0136672. PubMed ID: 26366562
[TBL] [Abstract][Full Text] [Related]
28. Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia.
Orringer EP; Blythe DS; Johnson AE; Phillips G; Dover GJ; Parker JC
Blood; 1991 Jul; 78(1):212-6. PubMed ID: 1712641
[TBL] [Abstract][Full Text] [Related]
29. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
[TBL] [Abstract][Full Text] [Related]
30. Physiologic decline in fetal hemoglobin parameters in infants with sickle cell disease: implications for pharmacological intervention.
Marcus SJ; Ware RE
J Pediatr Hematol Oncol; 1999; 21(5):407-11. PubMed ID: 10524455
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea.
Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Winter WP; Castro O
Br J Haematol; 2002 Dec; 119(3):855-7. PubMed ID: 12437671
[TBL] [Abstract][Full Text] [Related]
32. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia.
Koshy M; Dorn L; Bressler L; Molokie R; Lavelle D; Talischy N; Hoffman R; van Overveld W; DeSimone J
Blood; 2000 Oct; 96(7):2379-84. PubMed ID: 11001887
[TBL] [Abstract][Full Text] [Related]
33. A clinically meaningful fetal hemoglobin threshold for children with sickle cell anemia during hydroxyurea therapy.
Estepp JH; Smeltzer MP; Kang G; Li C; Wang WC; Abrams C; Aygun B; Ware RE; Nottage K; Hankins JS
Am J Hematol; 2017 Dec; 92(12):1333-1339. PubMed ID: 28913922
[TBL] [Abstract][Full Text] [Related]
34. Cerebrovascular events in sickle cell-beta thalassemia treated with hydroxyurea: a single center prospective survey in adult Italians.
Rigano P; Pecoraro A; Calvaruso G; Steinberg MH; Iannello S; Maggio A
Am J Hematol; 2013 Nov; 88(11):E261-4. PubMed ID: 23828131
[TBL] [Abstract][Full Text] [Related]
35. Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea.
Ma Q; Wyszynski DF; Farrell JJ; Kutlar A; Farrer LA; Baldwin CT; Steinberg MH
Pharmacogenomics J; 2007 Dec; 7(6):386-94. PubMed ID: 17299377
[TBL] [Abstract][Full Text] [Related]
36. Hydroxyurea in children: present and future.
Vichinsky EP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):22-9. PubMed ID: 9317198
[TBL] [Abstract][Full Text] [Related]
37. Cellular effects of hydroxyurea in Hb SC disease.
Steinberg MH; Nagel RL; Brugnara C
Br J Haematol; 1997 Sep; 98(4):838-44. PubMed ID: 9326175
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea.
Ballas SK; Marcolina MJ; Dover GJ; Barton FB
Br J Haematol; 1999 May; 105(2):491-6. PubMed ID: 10233426
[TBL] [Abstract][Full Text] [Related]
39. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
Hebert N; Rakotoson MG; Bodivit G; Audureau E; Bencheikh L; Kiger L; Oubaya N; Pakdaman S; Sakka M; Di Liberto G; Chadebech P; Vingert B; Pirenne F; Galactéros F; Cambot M; Bartolucci P
Am J Hematol; 2020 Nov; 95(11):1235-1245. PubMed ID: 32681733
[TBL] [Abstract][Full Text] [Related]
40. Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia.
Keikhaei B; Yousefi H; Bahadoram M
Glob J Health Sci; 2015 Aug; 8(3):252-6. PubMed ID: 26493428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
